Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
Antipsychotic treatment experiences of people with bipolar I disorder: patient perspectives from an online survey
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
covidontheweb.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
title
Antipsychotic treatment experiences of people with bipolar I disorder: patient perspectives from an online survey
Creator
Baranwal, Nishtha
Bayliss, Martha
Bessonova, Leona
Carpenter-Conlin, Julia
Doane, Michael
Rychlec, Kaitlin
Sajatovic, Martha
Velligan, Dawn
Weiden, Peter
Yarlas, Aaron
O'sullivan, Amy
source
PMC
abstract
BACKGROUND: Oral antipsychotic (AP) medications are frequently prescribed to people with bipolar I disorder (BD-I). A cross-sectional online survey examined the experiences of people living with BD-I with a history of recent AP use. METHODS: Adults with self-reported physician-diagnosed BD-I (N = 200) who received oral APs during the prior year completed a survey on AP-related experiences, including side effects and their perceived burden on social functioning, adherence, and work. Items also assessed preferences for trade-offs (balancing symptom management and side effects) when considering a hypothetical new AP. The perceived impact of specific, prevalent side effects on adherence, work, and preferences for a hypothetical AP were also examined. Analyses were descriptive. RESULTS: The survey sample had a mean age of 43.2 (SD = 12.4) years, was 60% female, and 31% nonwhite. Almost all participants (98%) had experienced AP side effects. Common self-reported side effects were feeling drowsy or tired (83%), lack of emotion (79%), anxiety (79%), dry mouth (76%), and weight gain (76%). Weight gain was cited as the most bothersome side effect, rated by most participants (68%) as “very” or “extremely bothersome.” Nearly half of participants (49%) reported that AP side effects negatively impacted their job performance; almost all (92%) reported that side effects – most commonly anxiety and lack of emotion – negatively impacted social relationships (e.g., family or romantic partners). The most commonly-reported reason for stopping AP use was dislike of side effects (48%). Side effects most likely to lead to stopping or taking less of AP treatment included “feeling like a ‘zombie’” (29%), feeling drowsy or tired (25%), and weight gain (24%). When considering a hypothetical new AP, the most common side effects participants wanted to avoid included AP-induced anxiety (50%), weight gain (48%), and “feeling like a ‘zombie’” (47%). CONCLUSIONS: Side effects of APs were both common and bothersome, and impacted social functioning, adherence, and work. Findings highlight the prevailing unmet need for new APs with more favorable benefit-risk profiles.
has issue date
2020-07-10
(
xsd:dateTime
)
bibo:doi
10.1186/s12888-020-02767-x
bibo:pmid
32631362
has license
cc-by
sha1sum (hex)
c21a44e9411aeeb6f76b1d2d562eff4e9b23e7b1
schema:url
https://doi.org/10.1186/s12888-020-02767-x
resource representing a document's title
Antipsychotic treatment experiences of people with bipolar I disorder: patient perspectives from an online survey
has PubMed Central identifier
PMC7371473
has PubMed identifier
32631362
schema:publication
BMC Psychiatry
resource representing a document's body
covid:c21a44e9411aeeb6f76b1d2d562eff4e9b23e7b1#body_text
is
schema:about
of
named entity 'Antipsychotic'
named entity 'MEDICATIONS'
named entity 'bipolar I disorder'
named entity 'bipolar I disorder'
named entity 'Antipsychotic'
named entity 'anticonvulsant drugs'
named entity 'Hispanic'
named entity 'weight gain'
named entity 'weight gain'
named entity 'quality of life'
named entity 'emotion'
named entity 'symptom management'
named entity 'self-reported'
named entity 'sexual dysfunction'
named entity 'dry mouth'
named entity 'aripiprazole'
named entity 'schizophrenia'
named entity 'disease symptoms'
named entity 'anxiety'
named entity 'symptom'
named entity 'weight gain'
named entity 'cross-sectional'
named entity 'weight gain'
named entity 'olanzapine'
named entity 'emotion'
named entity 'manic episode'
named entity 'drug development'
named entity 'dyslipidemia'
named entity 'romantic relationships'
named entity 'weight gain'
named entity 'health care professional'
named entity 'Antipsychotic'
named entity 'sample size'
named entity 'job performance'
named entity 'general population'
named entity 'hypothesis testing'
named entity 'weight gain'
named entity 'female to male'
named entity 'social functioning'
named entity 'manic episodes'
named entity 'manic episode'
named entity 'disability'
named entity 'health care'
named entity 'interactions with friends'
named entity 'social activities'
named entity 'clinical practice'
named entity 'symptom management'
named entity 'Bipolar I disorder'
named entity 'social functioning'
named entity 'anxiety'
named entity 'Standard Deviation'
named entity 'dry mouth'
named entity 'drug development'
named entity 'Symptom'
named entity 'weight gain'
named entity 'weight gain'
named entity 'cross-sectional'
named entity 'anxiety'
named entity 'manic episodes'
named entity 'informed consent'
named entity 'Antipsychotic'
named entity 'social functioning'
named entity 'symptom management'
named entity 'sexual dysfunction'
named entity 'antidepressants'
named entity 'Cary, NC'
named entity 'antipsychotics'
named entity 'fainting'
named entity 'psychiatric disorders'
named entity 'weight gain'
named entity 'lithium'
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 5
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software